Interstitial lung disease endpoints

interstitial lung disease: A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of pulmonary alveoli that extends to the interstitium and beyond leading to diffuse pulmonary fibrosis. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.

Endpoint definition

FinnGen phenotype data

Filter registries None

Check pre-conditions None

diagram bullet diagram downward connector

Include endpoints

Check conditions None

Apply sex-specific rule None

diagram downward connector ILD_ENDPOINTS

Extra metadata

First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
Number of individuals 27356 16289 11067
Unadjusted prevalence (%) 10.52 11.08 9.79
Mean age at first event (years) 47.13 45.61 49.37


Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.03 2.41 [2.15, 2.70] 5.8e-52 2781
15 years 0.02 2.86 [2.60, 3.15] <1e-100 2266
5 years 0.01 4.69 [4.24, 5.20] <1e-100 1032
1 year 0.00 8.55 [7.31, 10.00] <1e-100 367


Index endpoint: ILD_ENDPOINTS – Interstitial lung disease endpoints
GWS hits: 27

Survival analyses between endpoints


before Interstitial lung disease endpoints
after Interstitial lung disease endpoints

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Interstitial lung disease endpoints